Physician profile
Lori E Coors
NPI 1427057223
$6,346.10
in general payments reported to CMS, 2019-2025
21 companies · $389 in 2025
The $389 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $14.06 · 2021: $3,715 · 2022: $590 · 2023: $786 · 2024: $451 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,625.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,699.74 | 2019-2021 | |
| Alimera Sciences, INC. | $397.59 | 2021-2024 | Iluvien, Yutiq |
| Regeneron Healthcare Solutions, INC. | $375.36 | 2019-2025 | Eylea Hd, Eylea |
| Genentech USA, INC. | $337.20 | 2022-2025 | Vabysmo |
| Abbvie INC. | $227.06 | 2019-2024 | Ozurdex |
| Horizon Therapeutics Plc | $227.05 | 2019-2023 | Tepezza |
| Bausch & Lomb Americas INC. | $224.29 | 2022-2025 | Xipere |
| Coherus Oncology, INC. | $219.34 | 2022-2024 | |
| Astellas Pharma US INC | $186.46 | 2023-2025 | Izervay |
| Apellis Pharmaceuticals, INC. | $91.47 | 2023 | Syfovre |
| Allergan, INC. | $65.95 | 2019-2021 | |
| Carl Zeiss Meditec USA, INC. | $65.38 | 2021-2022 | |
| Sandoz INC. | $59.83 | 2024 | Cimerli |
| Harrow Eye, LLC | $43.92 | 2025 | Iheezo |
| Optos, INC. | $30.26 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $20.52 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $19.33 | 2021 | |
| Eyepoint US, INC. | $18.07 | 2023 | |
| Dutch Ophthalmic, USA | $15.15 | 2022 | |
| Carl Zeiss Meditec, INC. | $12.26 | 2021 | |
| Travere Therapeutics, INC. | $9.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Coors listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.